About Primas Bioscience
Primas Bioscience is a Healthcare company based in Chennai (India) founded in 2019 by Kabilan Chandrasekaran and Muthu Dhanraj. Developer of omega 3 fatty acids nutritional supplements. Primas Bioscience has raised $506.57 thousand across 1 funding round from investors including Lakshmi Narayanan, T K Chandiran and Lakshmi Narayanan. The company has 1 employees. Primas Bioscience was last valued at $1.58 million in July 2022. Its Indian entity Primas Bioscience Private Limited reported revenue of ₹92.2 Lakh. Primas Bioscience offers products and services including DHA Omega-3 and Nutritional Supplements. Its focus areas include Life Sciences, Nutraceuticals Tech, Functional Foods and Beverages and Food Additives.
Company details
Primas Bioscience was founded in 2019 in Chennai, India, within the bioscience sector. Omega-3 fatty acids are manufactured using patented technology derived from microbial sources. Products such as PrimasDHA-10, PrimasDHA-40, and antioxidants have been created. These supplements are utilized to support immune system function and blood pressure regulation. Operations focus on nutritional supplement development for health applications.
- Headquarters Chennai, India
- Employees 1
- Founders Kabilan Chandrasekaran, Muthu Dhanraj
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website primasbioscience.com
- Legal Name Primas Bioscience Private Limited
- Date of Incorporation 22 May, 2019
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹92.2 Lakh
FY 2025 · +150% YoY
- Net Loss-₹1.71 Cr
FY 2025 · -185% margin
- EBITDA-₹67.8 Lakh
FY 2025 · -74% margin
- Total Equity Funding$506.57K (USD)
in 1 rounds
- Latest Funding Round$506.57K (USD), Angel Round
Jul 2022
- Employee Count1
Associated legal entities of Primas Bioscience
Primas Bioscience operates through Primas Bioscience Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Primas Bioscience Private Limited CIN U36999TN2019PTC129400 | Active | 22 May 2019 | Chennai, Tamil Nadu | ₹0.9 Cr | 11 | 4 | View details |
Products & Services of Primas Bioscience
Primas Bioscience offers a comprehensive portfolio of products and services, including DHA Omega-3 and Nutritional Supplements.
Provides essential fatty acids for brain and heart health benefits.
Offers omega-3 based solutions for immune and inflammatory support.
Funding Insights of Primas Bioscience
Primas Bioscience has successfully raised a total of $506.57K through 1 strategic funding round. The most recent funding activity was a Angel Round of $506.57 thousand completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $506,572
- Total Rounds 1
- Last Round Angel Round — $506,572
- First Round $506,572
(Jul 2022)
- Investors Count 3
All 1 funding rounds of Primas Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2022 | $506,572 | Angel Round | $1.58M | Lakshmi Narayanan, Lakshmi Narayanan |
| Date | Valuation | Stage |
|---|---|---|
| Jul 2022 | $1.58M | •••••••• |
Last known valuation $1.58M (Jul 2022). 3 investors in total: 0 institutional and 3 angel.
Investors in Primas Bioscience
Primas Bioscience has secured backing from 3 investors, including angel investors. Prominent investors backing the company include Lakshmi Narayanan, T K Chandiran and Lakshmi Narayanan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
LN Lakshmi Narayanan | unknown_b9057b1db2274684a | |||
TK T K Chandiran | unknown_e6c111c4a3344a46b | |||
LN Lakshmi Narayanan | Angel investor, ex-CEO of Cognizant, focused on tech and innovation | unknown_6832630354354d6eb |
Investor details for Primas Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Primas Bioscience Private Limited (Primas Bioscience)
Primas Bioscience Private Limited is the primary company behind Primas Bioscience. The board of Primas Bioscience Private Limited currently have 4 directors; the longest-serving is Chandhrasekaran Kabilan, appointed in 2019. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chandhrasekaran Kabilan DIN 08458889 | Managing Director | 22 May 2019 | 7 yrs 5 mo | Primas Bioscience Private Limited |
| Dhanraj Muthu DIN 08458890 | Director | 22 May 2019 | 7 yrs 5 mo | Primas Bioscience Private Limited |
| Prabakaran DIN 08730708 | Additional Director | 19 Feb 2021 | 5 yrs 8 mo | Primas Bioscience Private Limited |
| Anju Chadha DIN 08730706 | Additional Director | 19 Feb 2021 | 5 yrs 8 mo | Primas Bioscience Private Limited |
People of Primas Bioscience
2 people are tracked at Primas Bioscience (2 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Kabilan Chandrasekaran | Co-Founder | Leadership |
| Co-Founder | Leadership |
Complete people profiles for Primas Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Primas Bioscience
Figures of Primas Bioscience Private Limited, the primary company behind Primas Bioscience, for FY 2025. Revenue was ₹92.2 Lakh (+150% year on year). Net loss was -₹1.71 Cr (-185% margin). EBITDA was -₹67.8 Lakh (-74% margin). Revenue has grown at a compounded annual rate of +840% over three years.
- ₹92.2 LakhRevenue · FY 2025 · +150% YoY
- -₹1.71 CrNet loss · -185% margin
- -₹67.8 LakhEBITDA · -74% margin
- ₹19.3 LakhPaid-up capital
- 11Employees (provident fund records)
- +840%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Primas Bioscience Private Limited are on its company page.
Detailed financial statements for Primas Bioscience
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Primas Bioscience
3 dated milestones of Primas Bioscience across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Primas Bioscience is founded.
- Funding First funding round of $507K.
- Milestone Reaches Minicorn status.
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as Primas Bioscience (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 27.35 M | 362 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | |||
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 23.98 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Primas Bioscience
Primas Bioscience was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Primas Bioscience is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Primas Bioscience is a funded company, having raised a total of $506.57K across 1 funding round to date. The company's 1st funding round was a Angel Round of $506.57K, raised on Jul 2022.
Primas Bioscience has 1 employees.
The primary company behind Primas Bioscience, Primas Bioscience Private Limited, reported revenue of ₹92.2 Lakh for FY 2025, up 150% year on year.
Primas Bioscience was founded in 2019 in Chennai, India, within the bioscience sector. Omega-3 fatty acids are manufactured using patented technology derived from microbial sources. Products such as PrimasDHA-10, PrimasDHA-40, and antioxidants have been created. These supplements are utilized to support immune system function and blood pressure regulation. Operations focus on nutritional supplement development for health applications.
Primas Bioscience offers DHA Omega-3 and Nutritional Supplements.
Primas Bioscience has 3 investors. Key investors include Lakshmi Narayanan, T K Chandiran, and Lakshmi Narayanan.
The valuation of Primas Bioscience is $1.58M as of Jul 2022.
Primas Bioscience operates through Primas Bioscience Private Limited.
The legal entities of Primas Bioscience currently have 4 directors, including Prabakaran, Anju Chadha, Chandhrasekaran Kabilan and others.